BioMerieux (id:10602 BIM)
99.15 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/27/2024 1:21:58 PM)
Exchange open, closes in 4 hours 7 minutes
About BioMerieux
Market Capitalization 11.43B
bioMérieux S.A. develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemaseproducing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO BACT/ALERT 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction (PCR) system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated Identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST Gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDASB·R·A·H·M·S PCTTM, a specific marker of severe bacterial infections/sepsis. It also provides Biomérieux vision suite, a software that provides actionable information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE Monoplex PCR tests; NUCLISENS ranges, a product for automation of the molecular biology laboratory and extraction; EMAG system For DNA and RNA extraction; ESTREAM, an automated preparation station for samples to process PCR tests; GENE-UP and VERIFLOW ranges for detection of microorganisms for the food industry. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
| Headquarters (address) |
376 Chemin De l’Orme Marcy-l'Étoile 69280 France |
| Phone | 33 4 78 87 20 00 |
| Website | https://www.biomerieux.com |
| Employees | 13,409 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Ticker | BIM |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 88.25 - 111.50 |
| Market Capitalization | 11.43B |
| Dividend yield forward | 3.47 % |
| Dividend yield forward France (ID:70, base:257) | 16.26 % |
| P/E trailing | 27.81 |
| P/E forward | 21.12 |
| Price/Sale | 3.00 |
| Price/Book | 2.94 |
| Beta | 0.219 |
| EPS | 3.47 |
| EPS France (ID:70, base:331) | -1.54 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: BioMerieux has raised their dividend 3.47 years in a row. This is below the 41466.174000 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: BioMerieux has raised their dividend 14.25 years in a row. This is below the 24.033000 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: BioMerieux has raised their dividend 20.11 years in a row. This is above the 12.576000 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: BioMerieux has raised their dividend 10.04 years in a row. This is below the 10.158800 year average in the 'Diagnostics & Research' industry
Payout Ratio
Payout Ratio: BioMerieux has raised their dividend 24.50 years in a row. This is below the 147.849600 year average in the 'Diagnostics & Research' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: BioMerieux has raised their dividend 3.47 years in a row. This is below the 41466.174000 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: BioMerieux has raised their dividend 14.25 years in a row. This is below the 24.033000 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: BioMerieux has raised their dividend 20.11 years in a row. This is above the 12.576000 year average in the 'Diagnostics & Research' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: BioMerieux has raised their dividend 10.04 years in a row. This is below the 10.158800 year average in the 'Diagnostics & Research' industry
Payout Ratio
Payout Ratio: BioMerieux has raised their dividend 24.50 years in a row. This is below the 147.849600 year average in the 'Diagnostics & Research' industry